Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 13, 2025, titled "CuraTeQ Biologics receives approval for biosimilar Zefylti from UK s MHRA".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 13, 2025, titled "CuraTeQ Biologics receives approval for biosimilar Zefylti from UK s MHRA".